Back to search

Article

Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation Study

2025-11-26

Abstract excerpt

<h4>Background: </h4> : Our objective was to evaluate metformin prescribed at the time of SARS-CoV-2 infection on the risk of developing Long Covid (LC) in electronic health record data. <h4>Methods: </h4> : We conducted a new user analysis of metformin prescribed within 6 days of documented infection with severe acute respiratory coronavirus syndrome 2 (SARS-CoV- 2) versus experimental control: prescription for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8421a8b-4b88-5408-b696-6316ced0cadd
DOI
10.22541/au.176418398.81170401/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation StudyDOI 10.22541/au.176418398.81170401/v1
Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 TrialSemantic proximity
Metformin and Severe Post-COVID-19 Outcomes Among Individuals with Diabetes MellitusSemantic proximity
A protocol for assessment of interventions using a computational phenotype for Long COVIDSemantic proximity
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical TrialSemantic proximity
Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetesSemantic proximity
Use of molnupiravir: a Danish nationwide drug utilization studySemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort studySemantic proximity
GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusSemantic proximity
High-Throughput Observational Evidence Generation Using Linked Electronic Health Record and Claims DataSemantic proximity
Select a neighboring publication to make it the new centre.